Sally Beauty (SBH)
(Delayed Data from NYSE)
$11.10 USD
+0.37 (3.45%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $11.10 0.00 (0.00%) 5:24 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Price, Consensus and EPS Surprise
SBH 11.10 +0.37(3.45%)
Will SBH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SBH
Sally Beauty (SBH) Down 20% YTD: Macroeconomic Headwinds Hurt
Sally Beauty's (SBH) Strategic Initiatives Aid Amid Soft Traffic
SBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sally Beauty's (SBH) Growth Pillars & Happy Beauty Co. Solid
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
Solid Growth Pillars Aid Sally Beauty (SBH), Soft Traffic a Woe
Other News for SBH
Sally Beauty: This Undervalued Stock Could Surprise To The Upside
FDIS: Consumer Discretionary Dashboard For April
Sally Beauty price target lowered by $2 at TD Cowen, here's why
BosleyMD Introduces Exclusive Line Called BosleyMan and BosleyWoman at Sally Beauty
Piper Sandler Sticks to Its Buy Rating for Sally Beauty (SBH)